These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27819148)

  • 1. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.
    Jose A; Labala S; Venuganti VV
    J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
    Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
    AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma.
    Labala S; Jose A; Venuganti VV
    Colloids Surf B Biointerfaces; 2016 Oct; 146():188-97. PubMed ID: 27318964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles.
    Labala S; Jose A; Chawla SR; Khan MS; Bhatnagar S; Kulkarni OP; Venuganti VVK
    Int J Pharm; 2017 Jun; 525(2):407-417. PubMed ID: 28373100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy.
    Saengkrit N; Saesoo S; Srinuanchai W; Phunpee S; Ruktanonchai UR
    Colloids Surf B Biointerfaces; 2014 Feb; 114():349-56. PubMed ID: 24246195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles.
    Pan J; Ruan W; Qin M; Long Y; Wan T; Yu K; Zhai Y; Wu C; Xu Y
    Sci Rep; 2018 Jan; 8(1):1117. PubMed ID: 29348670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of siRNA/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA/5-FU loaded liposome nanocomplexes.
    Aslan M; Ozturk S; Shahbazi R; Bozdemir Ö; Dilara Zeybek N; Vargel İ; Eroğlu İ; Ulubayram K
    Eur J Pharm Biopharm; 2024 Oct; 203():114432. PubMed ID: 39097115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
    Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
    J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium.
    Vanaja K; S S; Murthy SN; Shivakumar HN
    Curr Drug Deliv; 2021; 18(4):421-432. PubMed ID: 33059549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection.
    Petrilli R; Eloy JO; Saggioro FP; Chesca DL; de Souza MC; Dias MVS; daSilva LLP; Lee RJ; Lopez RFV
    J Control Release; 2018 Aug; 283():151-162. PubMed ID: 29864476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
    Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
    Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological exploration of peptide-based cationic liposomes in siRNA delivery.
    Zhu Y; Meng Y; Zhao Y; Zhu J; Xu H; Zhang E; Shi L; Du L; Liu G; Zhang C; Xu X; Kang X; Zhen Y; Zhang S
    Colloids Surf B Biointerfaces; 2019 Jul; 179():66-76. PubMed ID: 30947085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy.
    Duan X; Mu M; Yan J; Bai L; Zhong L; Zhu Y; Pan H; Zhang M; Shi J
    Int J Nanomedicine; 2018; 13():1443-1456. PubMed ID: 29563798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
    Yao Y; Su Z; Liang Y; Zhang N
    Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.
    Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA
    J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
    Şalva E; Turan SÖ; Eren F; Akbuğa J
    Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat.
    Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K
    Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of curcumin on invasion of skin squamous cell carcinoma A431 cells.
    Wu J; Lu WY; Cui LL
    Asian Pac J Cancer Prev; 2015; 16(7):2813-8. PubMed ID: 25854367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
    Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
    J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis.
    Han I; Kim M; Kim J
    Exp Dermatol; 2004 Feb; 13(2):86-92. PubMed ID: 15009101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.